Abstract: Provided are compositions and methods for used in solubilizing, stabilizing and expressing proteins. The proteins are fusion proteins that contain a protein of interest. The fusion proteins contain segments of Ribose Binding Protein (RBP) or Maltose Binding Protein (MBP). The fusion proteins can have the RBP or MBP segments flanking the target protein, and the RBP or MBP segments can be in the fusion protein in the same orientation as they normally occur (except for being interrupted by the target protein) or the segments can be permuted. Novel segments of the RBP and MBP are provided and result in improved expression and/or solubility of the proteins. Some examples include one or a combination of two complete or partial Histidine tags. Some examples allow for the target protein to be separated from all or a part of the fusion protein such as by enzymatic or non-enzymatic cleavage.
Type:
Grant
Filed:
October 23, 2017
Date of Patent:
August 2, 2022
Assignee:
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Abstract: A device is provided that allows for repeated electrical connection of an integrated circuit. The device includes a top, an alignment plate, a connector and a bottom. The top, alignment plate, connector and bottom each have first and second sides facing opposite directions, with the top, alignment plate, connector and bottom being stacked in a vertical orientation. The top is vertically moveable relative to the alignment plate to secure the integrated circuit adjacent to an edge of the connector, with the edge extending from a space between the first and second sides thereof.
Type:
Grant
Filed:
October 19, 2020
Date of Patent:
August 2, 2022
Assignee:
The Research Foundation for The State University of New York
Abstract: Provided herein are compounds of Formula (I) and pharmaceutically acceptable salts or tautomers thereof which may inhibit adenylate-forming enzymes. Also provided are pharmaceutical compositions, kits, uses, and methods involving the inventive compounds for the treatment and/or prevention of an infectious disease (e.g., bacterial infection (e.g., tuberculosis, methicillin-resistant Staphylococcus aureus)).
Type:
Application
Filed:
February 7, 2020
Publication date:
July 28, 2022
Applicants:
Memorial Sloan-Kettering Cancer Center, The Research Foundation for The State University of New York
Inventors:
Derek Shieh Tan, Christopher E. Evans, Peter J. Tonge, Melissa Lynn Boby, Yuanyuan Si
Abstract: The present disclosure is directed to a microwell array comprising a plurality of wells of micro-size dimensions created on porous materials. The device can be used in various cell and tissue analytical activities, and can be formed using an etching, laminating or imprinting processes.
Type:
Application
Filed:
May 8, 2020
Publication date:
July 21, 2022
Applicant:
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Inventors:
Eric BROUZES, Jin Zhu YU, Anu Priya Bharathi RAJAN, Jingfang JU, Gabor BALAZSI
Abstract: There is set forth herein a method including fabricating a photonics structure having one or more photonics device. The method can include forming one or more conductive material formation for communicating electrical signals to and/or from the one or more photonics device.
Type:
Application
Filed:
April 16, 2020
Publication date:
July 21, 2022
Applicant:
The Research Foundation for the State University of New York
Abstract: The present disclosure may be embodied as a transmitter for multiuser multicarrier-chirp-division-multiplexing (“MU-MCDM”) communications. The present disclosure may be embodied as a receive for MU-MCDM communications. The present disclosure may also be embodied as a method for transmitting an MU-MCDM communication signal. The present disclosure may also be embodied as a method for receiving an MU-MCDM communication signal.
Type:
Grant
Filed:
September 30, 2019
Date of Patent:
July 19, 2022
Assignee:
The Research Foundation for The State University of New York
Abstract: The present invention provides a compound having the structure: wherein R1 is H or a protecting group; R2 and R3 are each independently H, halo, C1-C6 alkyl, C2-C6 alkenyl, C2-C6 alkynyl, C1-C6 alkyl-C(O)NHR6, C1-C6 alkyl-C(O)OR6, wherein R6 is H, C1-C6 alkyl, C2-C6 alkenyl or C2-C6 alkynyl, or R2 and R3 combine to form a 3-7 membered cycloalkyl, heterocycloalkyl, aryl or heteroaryl ring; and R4 and R5 are each independently halo.
Type:
Application
Filed:
November 27, 2019
Publication date:
July 14, 2022
Applicant:
The Research Foundation for The State University of New York
Inventors:
Scott Laughlin, Pratik Kumar, Ting Jiang, Wei Huang
Abstract: Handheld, broadband terahertz (THz) scanners, housings therefor and imaging systems are provided. The scanner may comprise a 2-Dimensional (2D) gimbaled mirror for beam steering. The 2D gimbaled mirror may comprise a single minor mounted in a frame, a first motor and a second motor. The first motor and the second motor may be coupled to the frame. The minor may be rotatable in a first axis of rotation and a second axis of rotation to scan light on a target in two dimensions. The first motor corresponds to the first axis and the second motor corresponding to the second axis. The 2D gimbaled mirror may be positioned within the housing such that the single mirror is positioned at a focus of a focusing lens. The focusing lens may be fixed within a housing. The scanner may also comprise a terahertz emitter and detector.
Type:
Application
Filed:
March 11, 2020
Publication date:
July 14, 2022
Applicant:
The Research Foundation for The State University of New York
Abstract: One aspect of the present technology relates to a device. The device includes a sensor having an anode and a cathode. An operational amplifier (op-amp) having a single-ended output terminal, a non-inverting input, and an inverting input, is operatively coupled to one of the anode or the cathode of the sensor by the inverting input. A feedback resistor having a resistance of at least approximately one giga-ohm (1 G?) is operatively coupled between the single-ended output terminal and the inverting input of the op-amp. A grounded field shunt is positioned adjacent to the feedback resistor. The op-amp, grounded field shunt, and feedback resistor are disposed within an electrical shield enclosure. The single-ended output terminal of the op-amp terminates outside of the electrical shield enclosure.
Type:
Grant
Filed:
October 11, 2019
Date of Patent:
July 5, 2022
Assignee:
The Research Foundation for The State University of New York
Inventors:
Anthony Costantino, Arkadii Perzov, Arvydas Matiukas
Abstract: There is set forth herein a method including depositing a layer formed of barrier material over a conductive material formation of a photonics structure; and removing material of the layer in a light signal transmitting region of the photonics structure. In one embodiment the barrier material can include silicon carbon nitride. In one embodiment the barrier material can include silicon nitride.
Type:
Grant
Filed:
August 20, 2020
Date of Patent:
July 5, 2022
Assignee:
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Inventors:
Douglas Coolbaugh, Gerald L. Leake, Jr.
Abstract: Provided herein are compositions and nanocarriers comprising linear-dendritic telodendrimers (TD) containing riboflavin. The nanocarriers and compositions have desirable loading properties and stabilized structure and can be used for efficient in vivo delivery.
Type:
Grant
Filed:
January 19, 2018
Date of Patent:
June 28, 2022
Assignee:
The Research Foundation for the State University of New York
Abstract: A compound having an antiviral activity for inhibiting release of an enveloped virus from a cell is disclosed, including methods of inhibiting release of an enveloped virus from a cell. The antiviral activity of the compound includes inhibiting formation of an associative complex or disrupting formation of an associative complex. The associative complex comprises an L-domain motif of the enveloped virus and at least one cellular polypeptide, or fragment thereof, capable of binding the L-domain motif of the enveloped virus.
Type:
Grant
Filed:
August 5, 2020
Date of Patent:
June 28, 2022
Assignees:
Northwestern University, THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF
NEW YORK
Abstract: Described herein are RSV polynucleotide sequences that make use of multiple codons that are containing silent nucleotide substitutions engineered in multiple locations in the genome, wherein the substitutions introduce a numerous synonymous codons into the genome. Due to the large number of defects involved, the attenuated viruses disclosed herein provide a means of producing attenuated, live vaccines against RSV.
Type:
Grant
Filed:
March 16, 2018
Date of Patent:
June 28, 2022
Assignees:
THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES, THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK
Inventors:
Peter L. Collins, Cyril Le Nouën, Linda G. Brock, Ursula J. Buchholz, Joshua Marc DiNapoli, Steffen Mueller, Eckard Wimmer
Abstract: A system and method for monitoring and analyzing activities of a person operating a machine, particularly driving a vehicle, is provided. A first magnet is attached to a hand of the person and a second magnet is attached to the head of the person. A smart watch having a magnetometer is attached to the other hand of the person. The magnetometer is in magnetic communication with both the first magnet and the second magnet to generate a first magnetic signal and a second magnetic signal. Both signals can be received by a processor and applied to mathematical models by the processor to generate indicators representative of positions and motions of the hands and the head. An alarm can be generated based on the indicators.
Type:
Application
Filed:
April 24, 2020
Publication date:
June 16, 2022
Applicant:
The Research Foundation for The State University of New York
Abstract: The current disclosure provides methods for detecting and analyzing K17 expression in a bladder sample obtained from a subject. The current disclosure also pertains to methods and kits for identifying a mammalian subject with bladder cancer by detecting the expression of K17 in a sample. The present methods include both cell-based and cell-free methods for determining the level of keratin 17 in a sample obtained from the bladder of a subject.
Type:
Grant
Filed:
August 4, 2017
Date of Patent:
June 14, 2022
Assignees:
The Research Foundation for The State University of New York, KDx Diagnostics, Inc.
Inventors:
Kenneth R. Shroyer, Luisa F. Escobar-Hoyos, Nam Kim
Abstract: Synthetic disaccharide hydrocarbons (DSHs) that reactive bacterials swarming motility and inhibit bacterial adhesion and biofilm formation. A library of DSHs were tested in several experiment for the impact on various Pseudomonas aeruginosa populations and compared against existing compounds to determine efficacy and utility. Certain DSHs were also to determine the ability to clear bacteria in a mouse pneumonia model.
Type:
Grant
Filed:
October 2, 2020
Date of Patent:
June 14, 2022
Assignees:
Syracuse University, The Research Foundation for the State University of New York
Abstract: Provided is an implant, including a chamber having an interior radius wherein the interior radius has a flange, a cover slip, a cup, a setting member, a securing member, a resistance member, and an opposing member, wherein the cover slip, cup, resisting member, and setting member are attached to one another, the setting member sets on a flange and the securing member secures the setting member to the flange, the resistance member includes a flexibility and a longitudinal axis with a length wherein the flexibility permits modification of the length, and the opposing member sets a minimum length of the longitudinal axis. Also provided is a method of using said implant including affixing the chamber to a skull of a mammal.
Type:
Grant
Filed:
April 1, 2019
Date of Patent:
June 7, 2022
Assignee:
The Research Foundation for the State University of New York
Inventors:
Stephen Macknik, Olivya Caballero, Manuel Ledo, Susana Martinez-Conde
Abstract: Disclosed is a method of delivering therapeutic carbon monoxide to the cells and tissues of a patient which comprises administering thereto a compound of the formula XBY1Y2C(O)V (I) or pharmaceutically acceptable salts thereof. In addition, disclosed is a method of delivering a drug to a diseased cell or tissue by administering a compound of formula I either wherein at least one of X is a drug containing an amino group or V is a drug containing an amino group or hydroxyl group less a hydrogen on the amino or hydroxyl group. Further disclosed are novel compounds of Formula I.
Type:
Grant
Filed:
April 30, 2020
Date of Patent:
June 7, 2022
Assignees:
THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK, FLORIDA SHOUTHWESTERN STATE COLLEGE, UNIVERSITY OF ALASKA ANCHORAGE
Inventors:
Nin N. Dingra, Theppawut Israsena Na Ayudhya
Abstract: A method of synthesizing an electrode material for lithium ion batteries from Fe3O4 nanoparticles and multiwalled carbon nanotubes (MWNTs) to yield (Fe3O4-NWNTs) composite heterostructures. The method includes linking the Fe3O4 nanoparticles and multiwalled carbon nanotubes using a ?-? interaction synthesis process to yield the composite heterostructure electrode material. Since Fe3O4 has an intermediate voltage, it can be considered an anode (when paired with a higher voltage material) or a cathode (when paired with a lower voltage material).
Type:
Grant
Filed:
January 17, 2019
Date of Patent:
May 31, 2022
Assignee:
The Research Foundation for the State University of New York
Inventors:
Stanislaus Wong, Lei Wang, Coray McBean, Amy C. Marschilok, Kenneth Takeuchi, Esther S. Takeuchi